Format

Send to

Choose Destination
J Pediatr Adolesc Gynecol. 2017 Oct;30(5):520-534. doi: 10.1016/j.jpag.2017.04.001. Epub 2017 Apr 24.

Congenital Adrenal Hyperplasia.

Author information

1
Division of Pediatric Endocrinology, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: selma.witchel@chp.edu.

Abstract

The congenital adrenal hyperplasias comprise a family of autosomal recessive disorders that disrupt adrenal steroidogenesis. The most common form is due to 21-hydroxylase deficiency associated with mutations in the 21-hydroxylase gene, which is located at chromosome 6p21. The clinical features associated with each disorder of adrenal steroidogenesis represent a clinical spectrum that reflect the consequences of the specific mutations. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and preservation of fertility. For adolescent and adult men, prevention and early treatment of testicular adrenal rest tumors is beneficial. In this article key aspects regarding pathophysiology, diagnosis, and treatment of congenital adrenal hyperplasia are reviewed.

KEYWORDS:

Ambiguous genitalia; CYP21A2; Congenital adrenal hyperplasia; Hyperandrogenism; Premature adrenarche; Premature pubarche

PMID:
28450075
PMCID:
PMC5624825
DOI:
10.1016/j.jpag.2017.04.001
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center